[Deep venous thrombosis and pulmonary embolism. Prophylaxis and therapy].
Venous thromboembolism is a common cause of morbidity and mortality with an estimated annual incidence of 1:1,000. Several patient groups at risk can be differentiated, according to the presence of endogenous factors (such as hereditary thrombophilic disorders), but much more by exogenous factors (underlying disease). This results in risk-adapted recommendations for prophylaxis and therapy, which will be discussed in the following overview.
Beyer
Jan
J
Bereich Angiologie, Medizinische Klinik III, Universitätsklinikum Carl Gustav Carus der Technischen Universität Dresden, Dresden.
Schellong
Sebastian
S
D000925:Anticoagulants / Q000008:administration & dosage*; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D011655:Pulmonary Embolism / Q000188:drug therapy* / Q000517:prevention & control*; D020246:Venous Thrombosis / Q000188:drug therapy* / Q000517:prevention & control*
D000925:Anticoagulants; D005343:Fibrinolytic Agents